Axcella Therapeutics (NASDAQ: AXLA) mesmerized investors yesterday with news of a patent to treat fatigue in Long COVID. The short squeeze setup...
Bioxytran Inc. (OTCMKTS: BIXT) is perhaps one of the most undervalued biotechs in OTC. There is a real chance that if this...
CytoDyn Inc. (OTCMKTS: CYDY) announced today it was collaborating with the United Kingdom’s Department of Health to provide emergency access to ler...
Bioxytran Inc. (OTCMKTS: BIXT) has a development stage hypoxia drug that that was initially targeting Acute Respiratory Distress Syndrome (ARDS) an...